|
Washington
(H24N).
Calling it one of the deadliest cancers affecting women today, President
Bill Clinton declared the week of Sept. 17 National Ovarian Cancer
Awareness Week in order to raise awareness about the disease.
Clinton
cited encouraging statistics that with early detection the disease
is very treatable. But he also pointed to the fact that most women
do not get screened for the cancer, and late detection and treatment
result in low success rates.
"Currently
75 percent of new cases [of ovarian cancer] are not diagnosed until
the disease is in its late stages of development, when treatment
in less effective," Clinton said in his proclamation. "With
early detection, women have a survival rate of over 90 percent;
diagnosis in its later stages, however, dramatically reduces the
chances of survival to just 25 percent."
There
is currently no reliable and quick way to screen for ovarian cancer,
according to the National Ovarian Cancer Coalition, whose founder,
Gail Hayward, recently died of the disease.
In
designating this week Ovarian Cancer Awareness, the president said
it "offers us an invaluable opportunity to educate Americans
about the symptoms and risk factors of the disease" and to
alert health care providers about the risks and symptoms involved
with its diagnosis.
Ovarian
cancer is diagnosed when cancerous cells are found in the one or
both of the two small ovaries that produce the female hormones and
store the eggs necessary for reproduction.
In
terms of prevalence, the disease is fifth among new cancer cases,
accounting for 4 percent of all cancers in women.
A
variety of symptoms may indicate the disease:
- Pelvic
and/or abdominal pain.
- Unexplained
changes in bowel habits.
- Unexplained
changes in weight, either losses or gains.
- Pain during
intercourse.
With
no effective ovarian cancer test available, women, especially those
who are at high risk, are encouraged to receive an annual vaginal
exam. Women considered to be at high risk are those who exhibit
warning signs, those who have a family history of breast, ovarian
and uterine cancers, and those of Jewish and Eastern European descent.
|